Stopping TKIs In CML Deemed Safe, Feasible

(MedPage Today) -- Study Authors: Ehab Atallah, Charles A. Schiffer, et al.; Theodore P. Braun and Brian J. DrukerTarget Audience and Goal Statement: Oncologists, hematologistsThe goal was to assess outcomes after stopping tyrosine kinase inhibitors...